InMed-logo-01
Subscribe
NASDAQ_Logo

Press Releases

Press Releases

InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
InMed Pharmaceuticals to Report Full Year Fiscal 2022 Financial Results and Business Update on September 23, 2022
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
InMed Pharmaceuticals Provides Update on its Core Research and Development Programs and BayMedica Business
InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria
InMed Announces Changes to its Board of Directors
InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
InMed Announces Appointment of Chief Operating Officer
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
Displaying 1 - 10 of 217
InMed-logo-mono
#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Manufacturing

Pharmaceutical

Investor

Products

About

Learn

© Copyright 2022 InMed Pharmaceuticals Inc.